StockNews.com Initiates Coverage on Retractable Technologies (NYSE:RVP)

Investment analysts at StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVPGet Free Report) in a research note issued on Thursday. The brokerage set a “hold” rating on the stock.

Retractable Technologies Price Performance

Shares of RVP opened at $0.76 on Thursday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.54 and a current ratio of 9.51. Retractable Technologies has a 52-week low of $0.71 and a 52-week high of $1.34. The business’s 50 day moving average price is $0.90 and its two-hundred day moving average price is $1.03. The firm has a market cap of $22.72 million, a PE ratio of -1.24 and a beta of 2.06.

Retractable Technologies (NYSE:RVPGet Free Report) last issued its earnings results on Wednesday, August 14th. The company reported ($0.48) earnings per share for the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%. The firm had revenue of $6.03 million for the quarter.

Insider Transactions at Retractable Technologies

In related news, CEO Thomas J. Shaw purchased 71,422 shares of the firm’s stock in a transaction that occurred on Friday, September 20th. The stock was acquired at an average price of $0.82 per share, for a total transaction of $58,566.04. Following the completion of the acquisition, the chief executive officer now owns 14,743,907 shares of the company’s stock, valued at $12,090,003.74. This represents a 0.00 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have bought 182,128 shares of company stock valued at $166,565 over the last ninety days. 55.00% of the stock is owned by company insiders.

About Retractable Technologies

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

See Also

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.